Study of OMP-336B11

Trial Profile

Study of OMP-336B11

Planning
Phase of Trial: Phase I

Latest Information Update: 02 Aug 2017

At a glance

  • Drugs OMP 336B11 (Primary)
  • Indications Cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 02 Aug 2017 According to a company media release, OncoMed expects to enroll the first-patient in this trial in 2H17.
    • 20 Jan 2017 New trial record
    • 05 Jan 2017 According to an OncoMed Pharmaceuticals media release, company is planning to file an IND in the first half of 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top